SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.2% of their position (5K shares) of IRADIMED CORP on the open market
Open‑market sale worth $451.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/24/2025ACC: 0001613801-25-000033
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-5K
Net shares
Net seller
$451.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
5K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−556.00
Price / share
$89.67
Trade value
$49.86K
% of position
0.0%
11/24/2025
2.31M→2.31M
Common Stock
Indirect
Shares
−3.56K
Price / share
$90.31
Trade value
$321.32K
% of position
0.2%
11/24/2025
2.31M→2.31M
Common Stock
Indirect
Shares
−886.00
Price / share
$91.01
Trade value
$80.63K
% of position
0.0%
11/24/2025
2.31M→2.31M
Total
Net shares
−5K
Net value
-$451.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/24/2025 | S · Sale | −556.00 | $89.67 | $49.86K | 0.0% | 2.31M | 2.31M |
| Common Stock Indirect | 11/24/2025 | S · Sale | −3.56K | $90.31 | $321.32K | 0.2% | 2.31M | 2.31M |
| Common Stock Indirect | 11/24/2025 | S · Sale | −886.00 | $91.01 | $80.63K | 0.0% | 2.31M | 2.31M |
| Total | −5K | -$451.81K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.06M
Common Stock
IndirectShares owned162.95K
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.06M | Indirect |
| Common Stock | 162.95K | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported